ALA

product on market Powder NutraBio Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for ALA
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Scoop(s)
Serving Size
833
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 200.0mg (198 products) 6 studies — no high-quality reviews

Other Ingredients

Absolutely None
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

1 serving 8-16oz 1-2xdaily with food

Suggested Use: As a dietary supplement, take 1-2 serving(s) daily with a meal or as directed by your physician. We advise using an accurate milligram weight scale to measure out each serving as measuring by volume is not always accurate.

Warnings & Precautions

Warning: Not intended for use by persons under the age of 18. Keep out of the reach of children.

If you are pregnant, breastfeeding, have known medical conditions (including kidney or liver disease) or are taking prescription or OTC medication(s) consult with your health care practitioner before using this product.

People with Vitamin B12 deficiency should avoid Alpha Lipoic Acid as its use may cause a worsening of symptoms. Capsule is recommended for oral use. This product is very acidic and should not be taken orally unless encapsulated or buffered. Oral use of powder can cause burning of the esophagus.

Formulation Notes

Vegetarian

Allergen Free -Non-GMO -Gluten Free -BSE/TSE Free

No fillers -No excipients -No additives

Free of Harmful Impurities

Additional Information

Manufactured in a GMP & FDA Inspected Facility

Quality and purity since 1996. NutraBio manufactures in our own FDA registered & inspected GMP facility complying with FDA 21 CFR Part 111 regulations.

100% Pure / Potent Antioxidant

Store in a cool place.

Serving scoop included (May settle to the bottom during shipping.)

Since 1996

OU

23173-001 B20222-03

Pharmaceutical Grade, HPLC Lab Tested for Potency

Powder

True Label Full Label Disclosure

Made in a GMP & FDA Inspected Facility

Metadata

Product Details

UPC / SKU6 49908 23173 6
DSLD Entry Date2015-09-25
Product TypeNon-Nutrient/Non-Botanical
FormPowder
DSLD ID50812
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.